Scott Kerns

4.3k total citations · 1 hit paper
7 papers, 905 citations indexed

About

Scott Kerns is a scholar working on Physiology, Genetics and Immunology. According to data from OpenAlex, Scott Kerns has authored 7 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 3 papers in Genetics and 3 papers in Immunology. Recurrent topics in Scott Kerns's work include Virus-based gene therapy research (3 papers), Lysosomal Storage Disorders Research (3 papers) and Retinal Development and Disorders (2 papers). Scott Kerns is often cited by papers focused on Virus-based gene therapy research (3 papers), Lysosomal Storage Disorders Research (3 papers) and Retinal Development and Disorders (2 papers). Scott Kerns collaborates with scholars based in United States. Scott Kerns's co-authors include Kiyotaka Kugiyama, Robert Roberts, Philip D. Henry, Joel D. Morrisett, Peter J. Henry, Nagesh Kalakonda, Amit Bhargava, Stephen F. Stanziale, Yuman Fong and Brendon M. Stiles and has published in prestigious journals such as Nature, Circulation Research and Investigative Ophthalmology & Visual Science.

In The Last Decade

Scott Kerns

7 papers receiving 879 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

1990 740 citations Kiyotaka Kugiyama, Scott Kerns et al. Nature profile →

Peers

Countries citing papers authored by Scott Kerns

Since Specialization

Citations

This map shows the geographic impact of Scott Kerns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Kerns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Kerns more than expected).

Fields of papers citing papers by Scott Kerns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Kerns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Kerns. The network helps show where Scott Kerns may publish in the future.

Co-authorship network of co-authors of Scott Kerns

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Kerns. A scholar is included among the top collaborators of Scott Kerns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Kerns. Scott Kerns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Dual AAV vector strategy for expression of large genes targeted for Stargardt disease gene therapy development 2021 ·Investigative Ophthalmology & Visual Science ·(unknown), Scott Kerns, Brian M. Kevany, Linas Padegimas	2
2	AAV gene therapy for the treatment of Fabry disease: A novel capsid with improved tropism to heart, kidney and CNS and improved GLA expression 2019 ·Molecular Genetics and Metabolism ·Brian M. Kevany, Scott Kerns, Linas Padegimas, Timothy J. Miller	3
3	An improved, novel, systemically administered AAV gene therapy for treatment of CLN3 juvenile neuronal ceroid lipofuscinosis 2019 ·Molecular Genetics and Metabolism ·Scott Kerns, Mark Arnold, Amy L. Aldrich, Rachel W. Fallet, Tammy Kielian, Linas Padegimas, Timothy J. Miller	1
4	Intravenous administration of CLN3 gene therapy for juvenile neuronal ceroid lipofuscinosis 2018 ·Molecular Genetics and Metabolism ·Scott Kerns, (unknown), Megan E. Bosch, Rachel W. Fallet, Jessica Odvody, (unknown), Kaye Spratt, Tammy Kielian	1
5	Oncolytic Herpes Simplex Virus-1 Mutant Expressing Green Fluorescent Protein Can Detect and Treat Peritoneal Cancer 2004 ·Human Gene Therapy ·Stephen F. Stanziale, Brendon M. Stiles, Amit Bhargava, Scott Kerns, Nagesh Kalakonda, Yuman Fong	33
6	Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. 1993 ·Circulation Research ·(unknown), Kiyotaka Kugiyama, (unknown), Scott Kerns, Peter J. Henry	125
7	Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins breakdown → 1990 ·Nature ·Kiyotaka Kugiyama, Scott Kerns, Joel D. Morrisett, Robert Roberts, Philip D. Henry	740

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact